Navigate Fool.com
Will INSY beat
the market?


Community Rating: 1 Star: Ominous

27.63 0.33 (1.21%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.30
Previous Close $27.30
Daily Range $26.53 - $28.00
52-Week Range $10.29 - $57.91
Market Cap $945.8M
P/E Ratio 16.96
Dividend (Yield) $0.00 (0.0%)
Volume 363,834
Average Daily Volume 505,841
Current FY EPS $1.13

How do you think INSY
will perform against the market?

Top INSY Bull/Bear Pitches


crashchandler (0)
Submitted March 5, 2014

This company has created a new business plan to have this medication authorized by the insurance companies at the home office of INSY and taken it out of the hands of the perscribing physicians. … More

0 Replies Reply Report this Post

HoldThatWinner (< 20)
Submitted May 12, 2014

Fraudulent sales practices, reverse merger, very shady past (and present).

0 Replies Reply Report this Post

News & Commentary

Is This Marijuana Stock GW Pharmaceuticals' Biggest Risk?

Overly optimistic projections could mean that GW Pharma (GWPH) is overpriced.

Wednesday's Top Health Care Stories: Aerie, Insys, and Owens & Minor

Here’s why you need to watch Aerie, Insys, and Owens & Minor this Wednesday morning.

Shorts Are Piling Into These Stocks. Should You Be Worried?

Do short-sellers have these three stocks pegged? You be the judge!

Why Shorts Are Taking Aim at This Marijuana Stock

Short interest in Insys Therapeutics has spiked lately. Here's what you need to know.

Insys Therapeutics director buys 45,000 shares

Better Marijuana Stock: GW Pharma vs Insys

Marijuana stocks GW Pharma (GWPH) and Insys (INSY) have been on a roll this past year, but is one a better buy now than the other?

The 3 Biggest Biotech Crashes in May

Here's what you need to know about tumbling shares in Insys, Clovis, and Aegerion.

Healthcare Stocks Advancing; Insys Therapeutics Gains After Seeking FDA Support for Cannabidiol

Sector Update: Healthcare

3 Biotech Stocks Falling Like a Knife: Aegerion, Insys, and Prothena

When biotechs fall, they can create compelling buying opportunities for the long-term investor. Here is a Foolish look at three biotechs that have dropped in dramatic fashion in the last quarter.

See More INSY News...




INSYS THERAPEUTICS INC Website: http://www.insysrx.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks